Bajaj Healthcare Limited · NSE: BAJAJHCARE · BSE: 539872
Bajaj Healthcare
Quarterly results as filed with BSE. Latest: Q2 FY27 (Jul–Sep 2026), filed 17 Oct 2026.
Q2 FY27 · Standalone
Revenue
175.90₹ Cr
+18.9% vs year ago
Net profit
14.09₹ Cr
+26.9% vs year ago
EPS, basic
4.19₹
+18.7% vs year ago
Net margin
8.0%
+0.5 pts vs year ago
Quarter by quarter
| Quarter | Revenue | YoY | Net profit | YoY | EPS (₹) | Filed |
|---|---|---|---|---|---|---|
| Q2 FY27Jul–Sep 2026 | 175.90 | +18.9% | 14.09 | +26.9% | 4.19 | 17 Oct 2026 |
| Q1 FY27Apr–Jun 2026 | 165.63 | +11.3% | 13.70 | +15.8% | 4.07 | 20 Jul 2026 |
| Q4 FY26Jan–Mar 2026 | 153.06 | −0.9% | (22.85) | Turned loss | (7.16) | 08 May 2026 |
| Q3 FY26Oct–Dec 2025 | 161.22 | +31.3% | 15.67 | +33.7% | 4.96 | 16 Jan 2026 |
| Q2 FY26Jul–Sep 2025 | 147.91 | +11.1% | 11.11 | +17.4% | 3.53 | 17 Oct 2025 |
| Q1 FY26Apr–Jun 2025 | 148.84 | +12.5% | 11.83 | +65.9% | 3.74 | 28 Jul 2025 |
| Q4 FY25Jan–Mar 2025 | 154.47 | +15.4% | 11.18 | Turned profit | 3.54 | 26 May 2025 |
| Q3 FY25Oct–Dec 2024 | 122.79 | +13.1% | 11.72 | Turned profit | 3.65 | 12 Feb 2025 |
| Q2 FY25Jul–Sep 2024 | 133.09 | +31.5% | 9.46 | Turned profit | 3.36 | 15 Nov 2024 |
| Q1 FY25Apr–Jun 2024 | 132.25 | +1.9% | 7.13 | Turned profit | 2.59 | 30 Aug 2024 |
| Q4 FY24Jan–Mar 2024 | 133.90 | −15.5% | (29.92) | Turned loss | (10.84) | 14 Jun 2024 |
| Q3 FY24Oct–Dec 2023 | 108.57 | −23.5% | (2.20) | Turned loss | (0.80) | 22 Feb 2024 |
| Q2 FY24Jul–Sep 2023 | 101.21 | −49.6% | (3.46) | Turned loss | (1.25) | 23 Nov 2023 |
| Q1 FY24Apr–Jun 2023 | 129.74 | −24.6% | (48.21) | Turned loss | (17.46) | 14 Aug 2023 |
| Q4 FY23Jan–Mar 2023 | 158.44 | −9.8% | 3.59 | −79.4% | 1.30 | 31 May 2023 |
| Q3 FY23Oct–Dec 2022 | 141.88 | −15.3% | 11.05 | −36.6% | 4.01 | 16 Feb 2023 |
| Q2 FY23Jul–Sep 2022 | 200.89 | +33.1% | 16.36 | −5.2% | 5.93 | 23 Nov 2022 |
| Q1 FY23Apr–Jun 2022 | 172.07 | −7.3% | 12.02 | −37.5% | 4.35 | 06 Sep 2022 |
| Q4 FY22Jan–Mar 2022 | 175.71 | +32.9% | 17.47 | −17.9% | 6.33 | 21 May 2022 |
| Q3 FY22Oct–Dec 2021 | 167.57 | −6.0% | 17.45 | −34.0% | 6.32 | 28 Jan 2022 |
| Q2 FY22Jul–Sep 2021 | 150.91 | −27.0% | 17.25 | −14.2% | 6.25 | 03 Nov 2021 |
| Q1 FY22Apr–Jun 2021 | 185.69 | +32.8% | 19.22 | +25.7% | 13.93 | 03 Aug 2021 |
| Q4 FY21Jan–Mar 2021 | 132.18 | +11.5% | 21.28 | +121.6% | 15.42 | 10 Jun 2021 |
| Q3 FY21Oct–Dec 2020 | 178.33 | +79.6% | 26.42 | +314.1% | 19.15 | 29 Jan 2021 |
| Q2 FY21Jul–Sep 2020 | 206.63 | +105.5% | 20.12 | +513.8% | 14.58 | 03 Nov 2020 |
| Q1 FY21Apr–Jun 2020 | 139.83 | +52.5% | 15.29 | +371.7% | 11.08 | 15 Sep 2020 |
| Q4 FY20Jan–Mar 2020 | 118.50 | — | 9.60 | — | 6.96 | 04 Jul 2020 |
| Q3 FY20Oct–Dec 2019 | 99.27 | — | 6.38 | — | 4.62 | 14 Feb 2020 |
| Q2 FY20Jul–Sep 2019 | 100.55 | — | 3.28 | — | 2.38 | 19 Nov 2019 |
| Q1 FY20Apr–Jun 2019 | 91.69 | — | 3.24 | — | 2.35 | 18 Aug 2019 |
30 filings on record for this company.